T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
- PMID: 15864738
- DOI: 10.1007/s11373-004-8183-7
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
Abstract
Human mesenchymal stem cells (MSCs) were evaluated for their ability to activate allogeneic T cells in cell mixing experiments. Phenotypic characterization of MSCs by flow cytometry showed expression of MHC Class I alloantigens, but minimal expression of Class II alloantigens and costimulatory molecules, including CD80 (B7-1), CD86 (B7-2), and CD40. T cells purified from peripheral blood mononuclear cells (PBMCs) did not proliferate to allogeneic MSCs. Lack of response was not due to a deficiency of costimulation, since retroviral transduction of MSCs with either B7-1 or B7-2 costimulatory molecules did not result in lymphoproliferation. Although these results suggested that MSCs were immunologically inert or potentially tolerogenic, T cells cultured with MSCs produced IFN-gamma and displayed secondary kinetics to restimulation with PBMCs, indicating alloantigen priming rather than tolerance induction by the MSCs. To determine whether MSCs suppressed alloreactive T cells, MSCs were added to primary mixed lymphocyte reaction (MLR) cultures. MSCs suppressed cell proliferation when added at the initiation of culture or when added to an ongoing MLR culture. Suppression was dose-dependent, genetically unrestricted, and occurred whether or not MSCs were pretreated with IFN-gamma. MSCs in transwell chambers suppressed primary MLR cultures, indicating that suppression was mediated by soluble molecules. Analysis of cytokines in suppressed MLR cultures demonstrated up-regulation of IFN-gamma and IL-10, and down-regulation of TNF-alpha production relative to control cultures. We conclude that MSCs can initiate activation of alloreactive T cells, but do not elicit T cell proliferative responses due to active suppressive mechanisms.
Similar articles
-
Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.Rheumatology (Oxford). 2008 Jan;47(1):22-30. doi: 10.1093/rheumatology/kem284. Rheumatology (Oxford). 2008. PMID: 18077486
-
Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.Transplantation. 2007 Mar 27;83(6):783-90. doi: 10.1097/01.tp.0000258649.23081.a3. Transplantation. 2007. PMID: 17414713
-
Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.Cell Immunol. 2008 Feb;251(2):116-23. doi: 10.1016/j.cellimm.2008.04.003. Epub 2008 May 20. Cell Immunol. 2008. PMID: 18495100
-
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.Cell Res. 2010 May;20(5):510-8. doi: 10.1038/cr.2010.44. Epub 2010 Apr 6. Cell Res. 2010. PMID: 20368733 Review.
-
The immunomodulatory capacity of mesenchymal stem cells.Trends Mol Med. 2012 Feb;18(2):128-34. doi: 10.1016/j.molmed.2011.10.004. Epub 2011 Nov 25. Trends Mol Med. 2012. PMID: 22118960 Review.
Cited by
-
Mesenchymal stem cell-derived hepatocytes for functional liver replacement.Front Immunol. 2012 Jun 22;3:168. doi: 10.3389/fimmu.2012.00168. eCollection 2012. Front Immunol. 2012. PMID: 22737154 Free PMC article.
-
Mesenchymal stem cell therapy for refractory scleroderma: a report of 2 cases.Stem Cell Investig. 2016 Sep 19;3:48. doi: 10.21037/sci.2016.09.03. eCollection 2016. Stem Cell Investig. 2016. PMID: 27777937 Free PMC article.
-
Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience.Aging Med (Milton). 2019 Sep;2(3):142-146. doi: 10.1002/agm2.12079. Epub 2019 Sep 17. Aging Med (Milton). 2019. PMID: 31667462 Free PMC article.
-
Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility.Int J Mol Sci. 2023 Feb 24;24(5):4464. doi: 10.3390/ijms24054464. Int J Mol Sci. 2023. PMID: 36901900 Free PMC article. Review.
-
Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases.Transfus Med Hemother. 2008;35(4):313-318. doi: 10.1159/000140859. Epub 2008 Jul 17. Transfus Med Hemother. 2008. PMID: 21512648 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials